Stock Report

All about this stock under one free report Last Updated: 21-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Avantor (AVTR) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$15.52

up-down-arrow $-0.34 (-2.14%)

As on 18-Sep-2026 16:28EDT

Market cap

info icon

$10,497 Mln

Revenue (TTM)

info icon

$6,561 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.9

Div. Yield

info icon

0 %

Edit peer-selector-edit
Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Market cap ($ Mln)
 10,497 12,560 9,521 9,770 9,983
Revenue ($ Mln)
 6,561 1,505 613 2,589 785
Net Profit ($ Mln)
 -578.00 160.59 -188.05 222.40 41.54
Net Margin (%)
 -8.81 10.67 -30.68 8.59 5.29
RoE (%)
 -10.33 10.86 -28.10 3.04 1.97
Price to Earnings
 -- 78.15 -- 44.47 242.32
Price-To-Book
 1.91 8.19 14.13 1.36 4.76

Income Statement ($ Mln)

Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Operating Revenue arrow
6,561.10 1,504.87 612.84 2,589.30 785.10
Cost of Revenue arrow
4,473.00 483.98 127.96 1,245.50 384.30
Gross Profit arrow
2,139.40 942.44 393.22 1,343.60 347.62
Operating Expenses arrow
2,373.70 833.56 565.37 1,108.90 335.50
Operating Profit (EBIT) arrow
-285.60 187.34 -80.49 235.00 65.30
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
-472.00 203.83 -192.83 350.40 52.15
Provision for Tax arrow
106.00 43.24 -4.79 128.00 10.61
Profit after Tax (Net Income) arrow
-578.00 160.59 -188.05 222.40 41.54
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 93.19 0.00 0.00 0.00

Liabilities ($ Mln)

Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Shareholder's Funds arrow
5,630.20 1,530.77 682.49 7,173.90 2,112.03
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Non-Current Liabilities arrow
4,583.70 210.18 135.71 2,116.80 705.49
Current Liabilities arrow
1,382.00 233.78 102.33 961.30 132.66
Total Liabilities arrow
11,794.70 1,826.52 893.49 10,576.50 2,949.70

Assets ($ Mln)

Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Non-Current Assets arrow
9,133.70 630.60 404.74 7,231.50 1,749.63
Current Assets arrow
2,462.20 1,344.12 515.78 3,020.50 1,200.55
Total Assets arrow
11,794.70 1,826.52 893.49 10,576.50 2,949.70
Total Debt* arrow
3,697.80 212.71 102.84 1,203.70 690.94
Net Current Assets arrow
1,080.20 1,110.35 413.45 2,059.20 1,067.90

Cashflow ($ Mln)

Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Cash From Operating Activities arrow
623.80 238.66 -46.34 532.20 117.42
Cash Flow from Investing Activities arrow
-130.50 -404.59 -77.61 -189.70 -298.47
Cash from Financing Activities arrow
-409.40 26.53 11.89 -283.20 -15.21
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
ROCE (%) arrow
-5.43 11.76 -22.53 8.98 1.79
ROE (%) arrow
-10.33 10.86 -28.10 3.04 1.97
ROA (%) arrow
-4.08 7.95 -18.00 2.02 1.36
EBIT Margin (%) arrow
-4.47 13.63 -30.58 -5.99 9.87
Net Margin (%) arrow
-8.81 10.67 -30.68 8.59 5.29
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Revenue Growth (%) arrow
-1.57 17.55 41.55 1.37 16.49
EBIT Growth (%) arrow
-129.16 17.49 -116.42 -131.06 920.91
Net Profit Growth (%) arrow
-184.08 8.72 -102.66 -30.32 400.42
EPS Growth (%) arrow
-184.11 8.12 -96.88 -29.66 394.30
Book Value Growth (%) arrow
-9.82 17.33 -12.65 2.19 2.16

Valuation Ratios

 Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Price / Earnings arrow
-14.68 68.93 -34.59 -- 189.42
Price / Book Value arrow
1.91 8.19 14.13 -- 4.76
Dividend Yield (%) arrow
0.00 0.00 0.00 -- 0.00
EV/EBITDA arrow
112.35 55.05 -65.95 -- 81.30
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Debt to Equity arrow
0.65 0.00 0.00 0.11 0.26
Short term debt to equity ratio arrow
0.01 0.01 0.00 0.06 0.01
Current Ratio arrow
1.78 5.75 5.04 3.14 9.05
Quick Ratio arrow
1.18 3.86 4.46 2.33 7.64
Interest Coverage arrow
-1.64 157.91 -38.31 8.18 1.92

Operating Efficiency Ratios

 Avantor (AVTR) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Debtors to sales (%) arrow
17.36 12.65 22.67 17.06 20.09
Asset Turnover arrow
0.46 0.74 0.59 0.24 0.26
Receivable days arrow
58.79 46.54 60.95 65.39 72.41
Inventory Days arrow
64.13 331.92 193.84 221.09 146.53
Payable days arrow
58.13 26.16 60.19 37.02 29.05
Cash Conversion Cycle arrow
64.79 352.30 194.60 249.46 189.88
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...